ZNF311
geneOn this page
Summary
ZNF311 (zinc finger protein 311, HGNC:13847) is a protein-coding gene on chromosome 6p22.1, encoding Zinc finger protein 311 (Q5JNZ3). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 282890 — RefSeq curated summary.
At a glance
- GWAS associations: 29
- Clinical variants (ClinVar): 85 total
- MANE Select transcript:
NM_001382360
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13847 |
| Approved symbol | ZNF311 |
| Name | zinc finger protein 311 |
| Location | 6p22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000197935 |
| Ensembl biotype | protein_coding |
| Entrez | 282890 |
Gene structure
Transcript identifiers
Ensembl transcripts: 22 — 21 protein_coding, 1 retained_intron
ENST00000377179, ENST00000483450, ENST00000910907, ENST00000910908, ENST00000910909, ENST00000910910, ENST00000910911, ENST00000910912, ENST00000916441, ENST00000916442, ENST00000916443, ENST00000916444, ENST00000916445, ENST00000916446, ENST00000916447, ENST00000916448, ENST00000916449, ENST00000953056, ENST00000953057, ENST00000953058, ENST00000953059, ENST00000953060
RefSeq mRNA: 3 — MANE Select: NM_001382360
NM_001010877, NM_001350637, NM_001382360
CCDS: CCDS34357
Canonical transcript exons
ENST00000377179 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001613743 | 28999487 | 28999613 |
| ENSE00001727923 | 29005008 | 29005315 |
| ENSE00001767519 | 28999956 | 29000047 |
| ENSE00001804643 | 29003946 | 29004214 |
| ENSE00003493883 | 28998734 | 28998838 |
| ENSE00003537019 | 28994788 | 28996586 |
| ENSE00003563990 | 29003513 | 29003594 |
Expression profiles
Bgee: expression breadth ubiquitous, 127 present calls, max score 88.36.
FANTOM5 (CAGE): breadth broad, TPM avg 1.0699 / max 29.2694, expressed in 612 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 72445 | 0.5493 | 302 |
| 72446 | 0.5206 | 292 |
Top tissues by expression
131 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.36 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.88 | gold quality |
| cortical plate | UBERON:0005343 | 76.29 | gold quality |
| ventricular zone | UBERON:0003053 | 75.43 | gold quality |
| ganglionic eminence | UBERON:0004023 | 75.20 | gold quality |
| right uterine tube | UBERON:0001302 | 69.63 | gold quality |
| rectum | UBERON:0001052 | 68.15 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 67.20 | gold quality |
| endometrium | UBERON:0001295 | 66.99 | gold quality |
| tibial nerve | UBERON:0001323 | 66.60 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 66.22 | gold quality |
| ovary | UBERON:0000992 | 66.18 | gold quality |
| thyroid gland | UBERON:0002046 | 66.16 | gold quality |
| right ovary | UBERON:0002118 | 66.13 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 65.97 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 65.82 | gold quality |
| left ovary | UBERON:0002119 | 65.79 | gold quality |
| right testis | UBERON:0004534 | 65.33 | gold quality |
| testis | UBERON:0000473 | 65.08 | gold quality |
| fallopian tube | UBERON:0003889 | 65.03 | gold quality |
| stromal cell of endometrium | CL:0002255 | 64.49 | gold quality |
| prostate gland | UBERON:0002367 | 64.04 | gold quality |
| left testis | UBERON:0004533 | 63.96 | gold quality |
| transverse colon | UBERON:0001157 | 63.77 | gold quality |
| cortex of kidney | UBERON:0001225 | 63.65 | gold quality |
| ectocervix | UBERON:0012249 | 63.41 | gold quality |
| left coronary artery | UBERON:0001626 | 63.36 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 63.30 | gold quality |
| colonic epithelium | UBERON:0000397 | 63.23 | silver quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 63.03 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.64 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
50 targeting ZNF311, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
| HSA-MIR-4458 | 99.96 | 71.64 | 1650 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548BB-5P | 99.94 | 71.27 | 3509 |
| HSA-MIR-548C-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548D-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548H-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548I | 99.94 | 71.25 | 3481 |
Literature-anchored findings (GeneRIF, showing 1)
- Prognostic Biomarker ZNF311 and Its Correlation With Tumor Progression and Immune Infiltrates in Glioma. (PMID:33746099)
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 311 — Q5JNZ3 (reviewed: Q5JNZ3)
Alternative names: Zinc finger protein zfp-31
All UniProt accessions (2): A0A1U9X8W3, Q5JNZ3
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (3): NP_001010877, NP_001337566, NP_001369289* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050826 | Krueppel_C2H2_ZnFinger | Family |
Pfam: PF00096, PF01352, PF13912
UniProt features (18 total): zinc finger region 14, sequence variant 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5JNZ3-F1 | 65.02 | 0.11 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 26 (showing top):
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP, KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, SNIP1_TARGET_GENES, MIR3606_5P, MIR3129_3P, MIR5583_5P, AHRR_TARGET_GENES, DESCARTES_MAIN_FETAL_PDE1C_ACSM3_POSITIVE_CELLS, BRCA2_TARGET_GENES, HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, PULVER_FOREY_CELLCYCLE_PEAKING_S1
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
328 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF311 | EBLN2 | Q6P2I7 | 595 |
| ZNF311 | OR2B3 | O76000 | 580 |
| ZNF311 | OR12D3 | Q9UGF7 | 579 |
| ZNF311 | PHAF1 | Q9BSU1 | 570 |
| ZNF311 | OR2H2 | O95918 | 553 |
| ZNF311 | OR2W1 | Q9Y3N9 | 525 |
| ZNF311 | TEDC2 | Q7L2K0 | 505 |
| ZNF311 | CCDC185 | Q8N715 | 447 |
| ZNF311 | OR14J1 | Q9UGF5 | 447 |
| ZNF311 | ARHGAP36 | Q6ZRI8 | 418 |
| ZNF311 | ACYP2 | P14621 | 418 |
| ZNF311 | OR2J2 | O76002 | 402 |
| ZNF311 | MUC22 | E2RYF6 | 397 |
| ZNF311 | GNL1 | P36915 | 390 |
| ZNF311 | MICB | P79525 | 386 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF311 | CENPB | psi-mi:“MI:0914”(association) | 0.530 |
| GRB2 | ZNF311 | psi-mi:“MI:0915”(physical association) | 0.400 |
| M | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (13): NKTR (Affinity Capture-MS), TRIM39 (Affinity Capture-MS), CENPB (Affinity Capture-MS), GPALPP1 (Affinity Capture-MS), CENPB (Affinity Capture-MS), TRIM39 (Affinity Capture-MS), GPALPP1 (Affinity Capture-MS), CARKD (Affinity Capture-MS), NKTR (Affinity Capture-MS), ZNF311 (Affinity Capture-MS), ZNF311 (Affinity Capture-MS), ZNF311 (Cross-Linking-MS (XL-MS)), ZNF311 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A1YEP8, A1YEV9, A1YFW2, A1YG26, A1YG48, A1YG60, A2T6E3, A2T6V8, A2T712, A2T736, A2T7D2, A2T7F4, A2T7L7, A2T812, A6QNZ0, O14709, O15535, O43296, O43309, P10073, P17023, P17097, P49910, Q07231, Q12901, Q15776, Q16670, Q1LZ87, Q3MJ62, Q53GI3, Q571J5, Q5JNZ3, Q5RAE6, Q5RBX0, Q5RCD9, Q5RJ54, Q7Z7L9, Q86W11, Q8IZ26, Q8NF99
Diamond homologs: A1L1L7, A3KN32, A3KN36, A6NFI3, A6NM28, A6NN14, A6QLU5, A7MBI1, A8K8V0, A8MTY0, A8MWA4, B4DU55, C9JBD0, G3X9G7, O60765, O75290, O94892, O95780, P0C7X2, P10072, P15622, P16373, P16374, P17023, P17032, P17097, P17098, P21506, P52742, P59923, Q06730, Q08DG8, Q16587, Q29RZ4, Q2TL60, Q3V080, Q49AA0, Q4R6C2, Q4V8A8, Q5FWF6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
85 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 76 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1216 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:28996587:C:CC | acceptor_gain | 1.0000 |
| 6:28996588:T:C | acceptor_gain | 1.0000 |
| 6:28998801:C:CT | acceptor_gain | 1.0000 |
| 6:28999950:G:C | donor_gain | 1.0000 |
| 6:28999954:A:AC | donor_gain | 1.0000 |
| 6:28999955:C:CC | donor_gain | 1.0000 |
| 6:29003463:CTA:C | donor_gain | 1.0000 |
| 6:29003518:T:A | donor_gain | 1.0000 |
| 6:28996585:CA:C | acceptor_gain | 0.9900 |
| 6:29003462:A:AC | donor_gain | 0.9900 |
| 6:29003463:C:CC | donor_gain | 0.9900 |
| 6:29003474:G:C | donor_gain | 0.9900 |
| 6:29003512:CCG:C | donor_gain | 0.9900 |
| 6:28998729:CTCA:C | donor_loss | 0.9800 |
| 6:28998730:TCACC:T | donor_loss | 0.9800 |
| 6:28998731:CACC:C | donor_loss | 0.9800 |
| 6:28998732:A:T | donor_loss | 0.9800 |
| 6:28998802:A:T | acceptor_gain | 0.9800 |
| 6:28998839:C:CC | acceptor_gain | 0.9800 |
| 6:28998843:T:TC | acceptor_gain | 0.9800 |
| 6:29003594:CCTAT:C | acceptor_gain | 0.9800 |
| 6:28996588:T:TC | acceptor_gain | 0.9700 |
| 6:28998728:ACT:A | donor_loss | 0.9700 |
| 6:28998801:C:T | acceptor_gain | 0.9700 |
| 6:28998846:C:CT | acceptor_gain | 0.9700 |
| 6:28999981:T:C | donor_gain | 0.9700 |
| 6:29000043:TAGAG:T | acceptor_gain | 0.9700 |
| 6:29003463:C:CT | donor_gain | 0.9700 |
| 6:29003463:CTACA:C | donor_gain | 0.9700 |
| 6:29003464:T:TT | donor_gain | 0.9700 |
AlphaMissense
4453 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:28995142:A:C | F620L | 0.998 |
| 6:28995142:A:T | F620L | 0.998 |
| 6:28995144:A:G | F620L | 0.998 |
| 6:28995226:G:C | F592L | 0.997 |
| 6:28995226:G:T | F592L | 0.997 |
| 6:28995228:A:G | F592L | 0.997 |
| 6:28995394:G:C | F536L | 0.997 |
| 6:28995394:G:T | F536L | 0.997 |
| 6:28995396:A:G | F536L | 0.997 |
| 6:28995310:G:C | F564L | 0.996 |
| 6:28995310:G:T | F564L | 0.996 |
| 6:28995312:A:G | F564L | 0.996 |
| 6:28995730:G:C | F424L | 0.995 |
| 6:28995730:G:T | F424L | 0.995 |
| 6:28995732:A:G | F424L | 0.995 |
| 6:28995814:G:C | F396L | 0.995 |
| 6:28995814:G:T | F396L | 0.995 |
| 6:28995816:A:G | F396L | 0.995 |
| 6:28995478:G:C | F508L | 0.994 |
| 6:28995478:G:T | F508L | 0.994 |
| 6:28995480:A:G | F508L | 0.994 |
| 6:28996066:G:C | F312L | 0.994 |
| 6:28996066:G:T | F312L | 0.994 |
| 6:28996068:A:G | F312L | 0.994 |
| 6:28995898:G:C | F368L | 0.993 |
| 6:28995898:G:T | F368L | 0.993 |
| 6:28995900:A:G | F368L | 0.993 |
| 6:28995982:G:C | F340L | 0.992 |
| 6:28995982:G:T | F340L | 0.992 |
| 6:28995984:A:G | F340L | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000085829 (6:29003780 A>G,T), RS1000486984 (6:29007350 G>A,T), RS1000509969 (6:28997729 G>T), RS1000871080 (6:29001584 T>G), RS1000975135 (6:29002353 T>G), RS1001492772 (6:29005430 C>T), RS1001584159 (6:29003373 T>A,C), RS1001843809 (6:29004593 AT>A), RS1002034358 (6:28997037 C>T), RS1002550687 (6:29001670 A>G), RS1002853313 (6:29005186 C>T), RS1002963513 (6:28998220 G>A), RS1003220599 (6:29006375 G>C), RS1003291870 (6:29004920 T>C), RS1003301918 (6:28999819 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
29 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002194_1 | Social communication problems | 3.000000e-07 |
| GCST003518_58 | Daytime sleep phenotypes | 1.000000e-06 |
| GCST004521_112 | Autism spectrum disorder or schizophrenia | 3.000000e-26 |
| GCST004521_212 | Autism spectrum disorder or schizophrenia | 5.000000e-14 |
| GCST004521_43 | Autism spectrum disorder or schizophrenia | 2.000000e-27 |
| GCST004521_56 | Autism spectrum disorder or schizophrenia | 1.000000e-22 |
| GCST004521_58 | Autism spectrum disorder or schizophrenia | 1.000000e-17 |
| GCST004521_7 | Autism spectrum disorder or schizophrenia | 2.000000e-15 |
| GCST004521_73 | Autism spectrum disorder or schizophrenia | 8.000000e-11 |
| GCST004521_84 | Autism spectrum disorder or schizophrenia | 1.000000e-12 |
| GCST004521_91 | Autism spectrum disorder or schizophrenia | 1.000000e-11 |
| GCST004748_94 | Lung cancer | 3.000000e-12 |
| GCST004749_79 | Lung cancer in ever smokers | 9.000000e-08 |
| GCST004750_44 | Squamous cell lung carcinoma | 4.000000e-11 |
| GCST004866_25 | Alopecia areata | 9.000000e-07 |
| GCST006101_3 | Cardiometabolic and hematological traits | 3.000000e-26 |
| GCST007201_360 | Schizophrenia | 1.000000e-25 |
| GCST008839_516 | Height | 7.000000e-07 |
| GCST008916_89 | Asthma | 2.000000e-10 |
| GCST008921_4 | Asthma and major depressive disorder | 2.000000e-11 |
| GCST010142_16 | Fish- and plant-related diet | 2.000000e-10 |
| GCST010142_19 | Fish- and plant-related diet | 4.000000e-10 |
| GCST010142_34 | Fish- and plant-related diet | 7.000000e-09 |
| GCST010142_35 | Fish- and plant-related diet | 8.000000e-09 |
| GCST010142_42 | Fish- and plant-related diet | 1.000000e-08 |
| GCST010142_7 | Fish- and plant-related diet | 3.000000e-12 |
| GCST010242_402 | HDL cholesterol levels | 2.000000e-20 |
| GCST010702_75 | Subcortical volume (MOSTest) | 3.000000e-11 |
| GCST010703_272 | Brain morphology (MOSTest) | 7.000000e-16 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005427 | social communication impairment |
| EFO:0007828 | daytime rest measurement |
| EFO:0008111 | diet measurement |
| EFO:0004612 | high density lipoprotein cholesterol measurement |
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| GSK-J4 | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| trichostatin A | increases expression | 1 |
| avobenzone | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| jinfukang | increases expression | 1 |
| Fulvestrant | increases methylation | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Amiodarone | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Valproic Acid | increases expression | 1 |
| Vanadates | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW32 | HEK293 eGFP-ZNF311 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): alopecia areata, lung carcinoma, squamous cell lung carcinoma